On October 20, 2025, Citius Pharmaceuticals, Inc. announced a registered direct offering to sell 1,460,000 shares at $1.51 each and pre-funded warrants, expected to raise approximately $6 million, with net proceeds of about $5.5 million planned for commercial and developmental purposes.